Disappointing outlook for 2021 from Palantir
Palantir reported revenues of $322 million for the fourth fiscal quarter, topping the $300.7 million consensus. It had an adjusted EPS of 6 cents, higher than the 2 cents projected by analysts. In the past quarter, it closed deals with the FDA, PG&E, and the US army.
Overall, in 2020 announced a revenue per customer of $7.9 million, 41% higher than that reported in 2019. Also, its top 20 customers generated revenues 34% higher than the previous year, figures reaching $33.2 million.
For the quarter ending in March, Palantir expects its revenue to increase 45%, while analysts are looking for a 35% growth to $309.5 million.
However, for 2021 the revenue growth is seen lower than in 2020, at 30%.
Following the news, Palantir stock price fell 12.8%.
Stay updated with the latest financial news with CAPEX.com!
Sources: cnbc.com, investors.com
Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.
Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance and forecasts are not reliable indicators of future results.
